National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 4) (PB 32 of 2016) (Cth)
PB 32 of 2016
National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 4)
National Health Act 1953
I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 29 April 2016
PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
___________________________________________________________________________
Amendment instrument – Pharmaceutical benefits – early supply
1 Name of Instrument
(1) This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 4)
(2)This Instrument may also be cited as PB 32 of 2016.
2 Commencement
This Instrument commences on 1 May 2016.
3 Amendment of PB 120 of 2015
Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).
Schedule 1 Amendments
Schedule 1
omit:
| Auranofin | Capsule 3 mg | 20 | 60 | 5 |
Schedule 1, after entry for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium trihydrate) [Maximum Quantity: 30; Number of Repeats: 5]
insert:
| Esomeprazole and clarithromycin and amoxycillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin 500 mg (as trihydrate) | 20 | 1 | 0 |
Schedule 1, after entry for Paracetamol in the form Tablet 665 mg (modified release)
insert:
| Paritaprevir with ritonavir with ombitasvir and dasabuvir and ribavirin | Pack containing 56 tablets paritaprevir 75 mg with ritonavir 50 mg with ombitasvir 12.5 mg and 56 tablets dasabuvir 250 mg and 168 tablets ribavirin 200 mg | 20 | 1 | 5 |
| Paritaprevir with ritonavir with ombitasvir and dasabuvir and ribavirin | Pack containing 56 tablets paritaprevir 75 mg with ritonavir 50 mg with ombitasvir 12.5 mg and 56 tablets dasabuvir 250 mg and 56 tablets ribavirin 600 mg | 20 | 1 | 5 |
Schedule 1, omit entry for Tiludronic acid
0
0
0